About Anthony Santidrian
Form D filings for Calidi Biotherapeutics in 2023 list Anthony Santidrian as executive officer.
Anthony Santidrian first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Anthony Santidrian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anthony Santidrian works with at each company, as listed on that company's latest Form D.
Calidi Biotherapeutics, Inc. · Form D, Jun 29, 2023
AC
Allan Camaisa
CEO and director
HL
Heehyoung Lee
Director
JS
James Schoeneck
Director
AZ
Alfonso Zulueta
Director
BM
Boris Minev
Interim Chief Medical Officer
ST
Stephen Thesing
Chief Business Officer
TK
Tony Kalajian
Interim Chief Financial Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director
GN
George Ng
Director